IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Alnylam Pharmaceuticals

CUSIP: 02043QAC1 | TRACE | 1 institutional holders

Quarters

Q1 2026Q4 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2026

Silverback Asset Management LLC15,161,000
2.0% of portfolio›$14.1M
StyleTurnoverLocationFiled
Silverback Asset Management LLC
15,161,000$14.1M2.0%Agg GrowthMediumDurham, NC2026-05-21